These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 9097711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM, Maisano C, Scibilia J.
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [Abstract] [Full Text] [Related]

  • 4. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
    Gee JM, Douglas-Jones A, Hepburn P, Sharma AK, McClelland RA, Ellis IO, Nicholson RI.
    J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
    [Abstract] [Full Text] [Related]

  • 5. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
    MacGrogan G, Jollet I, Huet S, Sierankowski G, Picot V, Bonichon F, Coindre JM.
    Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
    [Abstract] [Full Text] [Related]

  • 6. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM, Kallioniemi OP, Isola JJ.
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Cancer; 1996 Jan 01; 77(1):164-71. PubMed ID: 8630925
    [Abstract] [Full Text] [Related]

  • 8. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F, Ferrero-Poüs M, Trassard M, Hacène K, Phillips E, Tubiana-Hulin M, Le Doussal V.
    Cancer; 2002 Apr 15; 94(8):2151-9. PubMed ID: 12001111
    [Abstract] [Full Text] [Related]

  • 9. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E, Kamina S, Athanassiadou S, Agnantis NJ.
    Anticancer Res; 1996 Apr 15; 16(5B):3141-7. PubMed ID: 8920782
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T, Funahashi H, Satoh Y, Takagi H.
    Jpn J Clin Oncol; 1993 Feb 15; 23(1):20-5. PubMed ID: 8096256
    [Abstract] [Full Text] [Related]

  • 13. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM, Kraegel SA, Madewell BR.
    J Comp Pathol; 1999 May 15; 120(4):321-32. PubMed ID: 10208729
    [Abstract] [Full Text] [Related]

  • 14. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
    Magno WB, Hirschfield L, Bhuiya T, Harrison G, Mir R.
    Conn Med; 1992 Dec 15; 56(12):667-9. PubMed ID: 1363223
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF.
    Mod Pathol; 1993 May 15; 6(3):290-4. PubMed ID: 8102204
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV.
    Mod Pathol; 1993 Nov 15; 6(6):663-8. PubMed ID: 7508113
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J.
    J Pathol; 1992 Dec 15; 168(4):357-63. PubMed ID: 1484317
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
    Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M.
    Clin Cancer Res; 1996 Jan 15; 2(1):147-54. PubMed ID: 9816101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.